Bausch Health Companies Inc.·4

Jul 2, 4:13 PM ET

WECHSLER AMY B 4

Research Summary

AI-generated summary

Updated

Bausch Health (BHC) Director Amy Wechsler Receives 1,394 RSUs

What Happened
Amy B. Wechsler, a director of Bausch Health Companies Inc. (BHC), was granted 1,394 restricted share units (RSUs) on 2026-06-30. The filing reports an acquisition value of $4.93 per unit, for a total reported value of $6,872. This was an award/compensation grant (not an open-market purchase or sale).

Key Details

  • Transaction date and price: 2026-06-30 at $4.93 per RSU (reported acquisition value).
  • Shares/units received: 1,394 RSUs; total reported value $6,872.
  • Shares owned after transaction: Not specified in the provided filing.
  • Footnote: F1 — RSUs were issued in lieu of cash board compensation for the quarter ending 6/30/2026; each RSU is a contingent right to receive one common share.
  • Filing date: 2026-07-02; no late-filing flag was indicated in the supplied data.

Context
RSUs are typically compensation awards that convert to actual shares only upon vesting or settlement; they represent a contingent right to receive stock rather than an immediate market purchase. Grants to directors as board compensation are common and do not by themselves indicate a personal buy/sell decision about the company’s near-term prospects.